Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside

X Bao, Y Liang, H Chang, T Cai, B Feng… - … and Targeted Therapy, 2024 - nature.com
Proprotein convertase subtilisin/kexin type 9 (PCSK9) has evolved as a pivotal enzyme in
lipid metabolism and a revolutionary therapeutic target for hypercholesterolemia and its …

The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy

CY Hsu, MN Abdulrahim, MA Mustafa, TM Omar… - Medical Oncology, 2024 - Springer
Proprotein convertase subtilisin/kexin type 9 (PCSK9), a well-known regulator of cholesterol
metabolism and cardiovascular diseases, has recently garnered attention for its emerging …

[HTML][HTML] Theoretical Framework and Emerging Challenges of Lipid Metabolism in Cancer

Q Gu, Y Wang, P Yi, C Cheng - Seminars in Cancer Biology, 2024 - Elsevier
Elevated lipid metabolism is one of hallmarks of malignant tumors. Lipids not only serve as
essential structural components of biological membranes but also provide energy and …

[PDF][PDF] Total Cholesterol Assay Kit (Colorimetric)

P Manual - cellbiolabs.com
Cholesterol is a lipid sterol that is produced in and transported throughout the bloodstream
in eukaryotes. Cholesterol is a critical compound used in the structure of cell membranes …